Benign Prostatic Hyperplasia (BPH)

The prostate is composed of glands and muscle. With increasing age these tissues grow, resulting in enlargement of the prostate (BPH). BPH is rare before age 40, but is present in about 80% of men by age 80. About half of these men will have symptoms from the enlarged prostate.  We do not know what causes BPH but it appears to be related to subtle changes in hormone production, which occur with aging and, possibly, as a result of environmental factors such as diet.

BPH is not a cancer. BPH causes problems because as the prostate enlarges, it compresses the urethra and blocks the passage of urine from the bladder. This can prevent the bladder from emptying, sometimes causing damage to the bladder and kidneys, or the inability to pass urine. These serious effects are relatively uncommon; the more usual result of BPH is bothersome symptoms while urinating.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.


2016 Step Up team

Step Up Challenge fundraiser: February 25, 2018

The annual Step Up Challenge, raising funds for Prostate Cancer Canada, takes place in Vancouver on Sunday February 25. Click here to sponsor our relay team as they climbs 379 floors. Click here to volunteer to help with the event.

It's a Snow Day poster

It's A Snow Day at Mt. Seymour: March 9

Mt. Seymour is hosting It's A Snow Day, a fundraiser for Prostate Cancer Foundation BC, on Friday March 9. The event will include slope time, a reception, and a silent auction. Click here for more details including how to register, donate and/or sponsor.




Work at the Vancouver Prostate Centre

Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.